Role of endogenous GLP-1 on arterial stiffness and renal haemodynamics following bariatric surgery

被引:2
作者
Moriconi, D. [1 ]
Bruno, R. M. [2 ]
Rebelos, E. [1 ]
Armenia, S. [1 ]
Baldi, S. [1 ]
Bonvicini, L. [1 ]
Taddei, S. [1 ]
Nannipieri, M. [1 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Via Roma 67, I-56126 Pisa, Italy
[2] Univ Paris Cite, Paris Cardiovasc Res Ctr PARCC, INSERM U970 Team 7, Paris, France
关键词
carotid distensibility; endogenous GLP-1; pulse wave velocity; renal resistive index; Y GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE-1; RESISTIVE INDEX; PHYSIOLOGY; EXPRESSION; CELLS;
D O I
10.1111/eci.14256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cardiovascular trials have revealed the positive impact of GLP-1 receptor agonists (GLP-1 RAs) on cardiovascular outcomes in type 2 diabetes (T2D). However, the specific effects of endogenous GLP-1 on arterial stiffness and renal function remain understudied. This study aimed to explore the influence of endogenous GLP-1 response post-bariatric surgery on arterial stiffness and renal haemodynamic. Methods Thirty individuals with morbid obesity and without T2D, scheduled for Roux-en-Y Gastric Bypass (RYGB), were included. Clinical parameters, 3-hour oral glucose tolerance test (OGTT) with serial sampling for glycaemia, GLP-1 and insulin, carotid-femoral pulse wave velocity (cf-PWV), carotid distensibility coefficient (carotid-DC) and renal resistive index (RRI) measurements were conducted pre-surgery and 1-year post-surgery. Participants were categorized into high-response and low-response groups based on their post-surgery increase in GLP-1 (median increase of 104% and 1%, respectively, pre- vs. post-surgery). Results Post-surgery, high-response group demonstrated a greater reduction in cf-PWV (p = .033) and a greater increase (p = .043) in carotid DC compared to low-response group. These enhancements were observed independently of weight loss or blood pressure changes. High-response group exhibited a reduction in RRI (p = .034), although this association was influenced by improvement in pulse pressure. Finally, a multivariate stepwise regression analysis indicated that the percentage increase of GLP1, Delta-GLP1((AUC))%, was the best predictor of percentage decrease in cf-PWV (p = .014). Conclusions Elevated endogenous GLP-1 response following RYGB was associated with improved arterial stiffness and renal resistances, suggesting potential cardio-renal benefits. The findings underscore the potential role of endogenous GLP-1 in influencing vascular and renal haemodynamics independent of traditional weight loss.
引用
收藏
页数:11
相关论文
共 32 条
[1]   2011 Compendium of Physical Activities: A Second Update of Codes and MET Values [J].
Ainsworth, Barbara E. ;
Haskell, William L. ;
Herrmann, Stephen D. ;
Meckes, Nathanael ;
Bassett, David R., Jr. ;
Tudor-Locke, Catrine ;
Greer, Jennifer L. ;
Vezina, Jesse ;
Whitt-Glover, Melicia C. ;
Leon, Arthur S. .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (08) :1575-1581
[2]   A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials [J].
Aroda, Vanita R. .
DIABETES OBESITY & METABOLISM, 2018, 20 :22-33
[3]   GLP-1 Receptor Expression Within the Human Heart [J].
Baggio, Laurie L. ;
Yusta, Bernardo ;
Mulvihill, Erin E. ;
Cao, Xiemin ;
Streutker, Catherine J. ;
Butany, Jagdish ;
Cappola, Thomas P. ;
Margulies, Kenneth B. ;
Drucker, Daniel J. .
ENDOCRINOLOGY, 2018, 159 (04) :1570-1584
[4]   The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study [J].
Bechlioulis, Aris ;
Markozannes, Georgios ;
Chionidi, Ifigeneia ;
Liberopoulos, Evangelos ;
Naka, Katerina K. ;
Ntzani, Evangelia E. ;
Liatis, Stavros ;
Rizzo, Manfredi ;
Rizos, Evangelos C. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (04)
[5]  
[Anonymous], 2020, Eur Heart J, V41, P4317, DOI [10.1093/eurheartj/ehz486, 10.1093/eurheartj/ehz828]
[6]   GLP-1 Response to a Mixed Meal: What Happens 10 Years after Roux-en-Y Gastric Bypass (RYGB)? [J].
Dar, Moahad S. ;
Chapman, William H., III ;
Pender, John R. ;
Drake, Almond J., III ;
O'Brien, Kevin ;
Tanenberg, Robert J. ;
Dohm, G. Lynis ;
Pories, Walter J. .
OBESITY SURGERY, 2012, 22 (07) :1077-1083
[7]   The physiological role of glucagon-like peptide-1 in the regulation of renal function [J].
Farah, Livia X. S. ;
Valentini, Vanessa ;
Pessoa, Thaissa D. ;
Malnic, Gerhard ;
McDonough, Alicia A. ;
Girardi, Adriana C. C. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (02) :F123-F127
[8]   Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes [J].
Heuvelman, Valerie D. ;
Van Raalte, Daniel H. ;
Smits, Mark M. .
CARDIOVASCULAR RESEARCH, 2020, 116 (05) :916-930
[9]  
Holst JJ, 2019, COMPR PHYSIOL, V9, P1339, DOI [10.1002/j.2040-4603.2019.tb00092.x, 10.1002/cphy.c180013]
[10]   The physiology of glucagon-like peptide 1 [J].
Holst, Jens Juul .
PHYSIOLOGICAL REVIEWS, 2007, 87 (04) :1409-1439